{
  "schemaVersion": 1,
  "organisationId": "O-1772ba0eacc340ee82267c968a663af2",
  "slug": "aptargroup-inc",
  "name": "APTARGROUP, INC.",
  "updatedAt": "2026-10-02T16:04:12.810688Z",
  "sections": [
    {
      "type": "OVERVIEW",
      "text": "AptarGroup, Inc. is a global supplier of dispensing, dosing, drug-delivery and product-protection technologies for pharmaceutical, beauty, food, beverage, personal-care and home-care markets. Its business is organized into three segments: Pharma, Beauty and Closures, with products including pharmaceutical delivery systems, beauty pumps and packaging, and dispensing caps and closures. [https://aptar.com/en-us/about-aptar] [https://aptar.com/en-us/pharmaceutical/delivery-routes/nasal-system-drug-delivery-oindp] [https://aptar.com/en-us/beauty] [https://aptar.com/en-us/closures/food]\n\nThe company describes its purpose as “to innovate and transform ideas into solutions that improve everyday life.” [https://aptar.com/en-us/about-aptar/values-purpose] Aptar reported FY2025 sales of approximately $3.8 billion and has more than 14,000 employees across 20 countries, with operations spanning North America, Latin America, Europe and Asia. [T12677752] [P103993891]\n[T12677752][P103993891][https://aptar.com/en-us/about-aptar][https://aptar.com/en-us/pharmaceutical/delivery-routes/nasal-system-drug-delivery-oindp][https://aptar.com/en-us/beauty][https://aptar.com/en-us/closures/food][https://aptar.com/en-us/about-aptar/values-purpose]",
      "updatedAt": "2026-10-02T16:04:12.810688Z"
    },
    {
      "type": "PRODUCTS",
      "text": "Aptar’s Pharma products include nasal pumps and single- or multidose devices for prescription medicines, consumer health, pain management and emergency therapies; metered-dose inhaler valves that meter aerosolized medication for pulmonary delivery; and ophthalmic and airless dermal-dispensing systems. Injectable offerings include vial stoppers and prefilled-syringe components such as plungers, rigid needle shields and tip caps. PremiumCoat® coated components are designed to protect container contents, including biologic formulations. Active-Polymer™ materials can be engineered to absorb moisture, emit aromas, reduce pathogens, or scavenge odor, oxygen or volatile organic compounds. Related services include drug-delivery development and regulatory support, plus connected devices, diagnostics and digital-health applications that can operate alone or alongside delivery devices.\n\nBeauty products include fragrance and skincare pumps, spray and lotion pumps, airless dispensing systems, cosmetic sampling systems and aerosol valves for personal-care and home-care applications. Aptar also offers dispensing closures and food-service trays. Closure designs include elastomeric flow control, directional or no-drip dispensing, inverted and e-commerce-capable formats, as well as lightweighted, recycled-resin and tethered options. Food and beverage applications include sauces, condiments, infant nutrition, bottled water, sports and energy drinks, juices and concentrated beverage flavorings. Named products include APF Futurity®, a recyclable multidose nasal-spray pump; the Unidose Liquid Nasal Spray System; Essencia, a fragrance pump available in refillable versions; and Micro Beverage Enhancer Closure, an 18-mm snap-on closure with a SimpliSqueeze® valve for controlled dispensing of beverage concentrates.\n\nFor FY2025, net sales were $3.777 billion: Pharma contributed $1.737 billion (about 46%), Beauty $1.309 billion (about 35%) and Closures $730.3 million (about 19%). Within Pharma sales, the reported approximate mix was prescription drug/digital health 51%, consumer healthcare 20%, injectables 19% and active material-science solutions 10%; Beauty sales were approximately 58% fragrance/facial skincare/color cosmetics, 37% personal care and 5% home care. Closures sales included approximately 49% food and 26% beverage, with the balance from other markets.\n[P26942401][P65778214][P34900642][P78931723][P32346963][P62218729][P118933469][P27589424][P24632469][P100769735][P86421320][P44323451][P40207684][P90183207][P71762180][P50825336][P145380155][P145380157][P145380171][P145380175][P145380187][P145380191][https://aptar.com/en-us/products/pharmaceutical-apf-futurity-nasal-spray-recyclable][https://aptar.com/en-us/products/pharmaceutical-uds-unidose-liquid-nasal-spray-system][https://aptar.com/en-us/products/essencia-elegant-fragrance-pump][https://aptar.com/en-us/products/micro-beverage-enhancer-closure][https://aptar.com/en-us/closures/dispensing-caps-closures-for-beverage]",
      "updatedAt": "2026-10-02T16:04:12.810688Z"
    },
    {
      "type": "GEOGRAPHY",
      "text": "AptarGroup’s 2025 Form 10-K reports manufacturing and sales operations in North America, Europe, Latin America (including Mexico), and Asia. By customer ship-to location, Europe generated about 49% of 2025 sales, while Asia and Latin America together accounted for about 20%. The company describes itself as a net exporter from Europe and a net importer into North America, Asia, and Latin America. [P103993891]\n\nReported 2025 sales included $1.071 billion in the United States (about 28.4% of consolidated sales), $513 million in France (13.6%), $164 million in Germany (4.3%), $202 million in Italy (5.3%), $195 million in Spain (5.2%), and $194 million in China (5.1%); other Europe contributed $788 million (20.9%) and other foreign countries $649 million (17.2%). Segment geographic revenue was $1.863 billion in Europe, $1.174 billion Domestic, $444 million in Asia, and $296 million in Latin America. Percentages are calculated from reported sales of $3.777 billion. [T1105276][T5594450]\n\nAt year-end 2025, AptarGroup had 57 manufacturing facilities: 11 in France, 6 in Germany, 8 in the rest of Europe including the United Kingdom, 9 in North America, 9 in Latin America, 10 in China, and 4 in other parts of Asia and the Middle East. Its corporate headquarters is in Crystal Lake, Illinois. The company reported approximately 14,000 full-time employees: 8,640 in EMEA, 2,930 in Asia and Latin America combined, and 2,430 in North America. [T14007812][P104401032][P5016807]\n[P103993891][T1105276][T5594450][T14007812][P104401032][P5016807]",
      "updatedAt": "2026-10-02T16:04:12.810688Z"
    },
    {
      "type": "SEGMENTS",
      "text": "AptarGroup reports three business segments. **Pharma** focuses on dispensing and drug-delivery systems, sealing solutions, and services for prescription drugs, consumer healthcare, injectables, active material science, and digital health. **Beauty** serves fragrance, facial skincare, color cosmetics, personal care, and home care markets with dispensing systems and sealing solutions. **Closures** supplies dispensing closures, sealing solutions, and food-service trays for food, beverage, personal care, home care, beauty, and other markets. [P301804]\n\nFor FY2025, segment shares of consolidated net sales were approximately **46.0% Pharma** ($1,737.5 million), **34.7% Beauty** ($1,309.4 million), and **19.3% Closures** ($730.3 million). Shares are calculated from reported segment revenue and consolidated net sales. [T12677752]\n[P301804][T12677752][T12677752][T12677752][T12677752]",
      "updatedAt": "2026-10-02T16:04:12.810688Z"
    },
    {
      "type": "HISTORY",
      "text": "AptarGroup traces its origins to aerosol-valve businesses established in the United States, France and Germany between 1940 and 1960. During the following decades, the business expanded from aerosol valves into spray valves, pumps and molded dispensing closures. Aptar became a stand-alone public company, and its shares began trading on the New York Stock Exchange on April 23, 1993. [https://aptar.com/en-us/about-aptar/history-of-innovation] [https://aptar.com/en-us/news-events/aptar-celebrates-30-years-as-a-publicly-traded-company] [https://investors.aptar.com/news/news-details/2018/Aptar-Announces-Chairman-King-Harris-to-Retire-in-May-George-Fotiades-Elected-as-Incoming-Chairman-of-the-Board-Two-New-Directors-Appointed/default.aspx]\n\nIn 2016, Aptar completed its acquisition of Mega Airless, extending its dispensing systems offering; in 2018, it acquired CSP Technologies, adding active-packaging technology. Stephan Tanda became president and CEO in 2017. Later acquisitions included a majority stake in Gulf Closures in 2023 and Sommaplast in 2025, extending Aptar’s manufacturing and pharmaceutical-packaging operations in the Middle East and Latin America, respectively. [https://investors.aptar.com/news/news-details/2016/AptarGroup-Completes-Acquisition-of-Mega-Airless/default.aspx] [https://aptar.com/en-us/news-events/aptar-completes-acquisition-of-csp-technologies] [P44244551] [https://aptar.com/en-us/news-events/aptar-closures-acquires-majority-stake-of-gulf-closures-adding-manufacturing-capabilities-in-the-middle-east] [https://aptar.com/en-us/news-events/aptar-acquires-sommaplast-a-specialized-provider-of-oral-dosing-pharma-packaging-solutions]\n[P44244551][https://aptar.com/en-us/about-aptar/history-of-innovation][https://aptar.com/en-us/news-events/aptar-celebrates-30-years-as-a-publicly-traded-company][https://investors.aptar.com/news/news-details/2018/Aptar-Announces-Chairman-King-Harris-to-Retire-in-May-George-Fotiades-Elected-as-Incoming-Chairman-of-the-Board-Two-New-Directors-Appointed/default.aspx][https://investors.aptar.com/news/news-details/2016/AptarGroup-Completes-Acquisition-of-Mega-Airless/default.aspx][https://aptar.com/en-us/news-events/aptar-completes-acquisition-of-csp-technologies][https://aptar.com/en-us/news-events/aptar-closures-acquires-majority-stake-of-gulf-closures-adding-manufacturing-capabilities-in-the-middle-east][https://aptar.com/en-us/news-events/aptar-acquires-sommaplast-a-specialized-provider-of-oral-dosing-pharma-packaging-solutions]",
      "updatedAt": "2026-10-02T16:04:12.810688Z"
    }
  ],
  "sources": [
    {
      "id": "https://aptar.com/en-us/about-aptar",
      "href": "https://aptar.com/en-us/about-aptar",
      "label": "aptar.com"
    },
    {
      "id": "https://aptar.com/en-us/pharmaceutical/delivery-routes/nasal-system-drug-delivery-oindp",
      "href": "https://aptar.com/en-us/pharmaceutical/delivery-routes/nasal-system-drug-delivery-oindp",
      "label": "aptar.com"
    },
    {
      "id": "https://aptar.com/en-us/beauty",
      "href": "https://aptar.com/en-us/beauty",
      "label": "aptar.com"
    },
    {
      "id": "https://aptar.com/en-us/closures/food",
      "href": "https://aptar.com/en-us/closures/food",
      "label": "aptar.com"
    },
    {
      "id": "https://aptar.com/en-us/about-aptar/values-purpose",
      "href": "https://aptar.com/en-us/about-aptar/values-purpose",
      "label": "aptar.com"
    },
    {
      "id": "T12677752",
      "href": "https://app.finbar.com/go?id=T12677752",
      "label": "APTARGROUP, INC. — Full financial report (2025 Y)",
      "documentId": "D-8ab120ff31d14209ba21d3b9b482703f"
    },
    {
      "id": "P103993891",
      "href": "https://app.finbar.com/go?id=P103993891",
      "label": "APTARGROUP, INC. — Full financial report (2025 Y)",
      "documentId": "D-8ab120ff31d14209ba21d3b9b482703f"
    },
    {
      "id": "P26942401",
      "href": "https://app.finbar.com/go?id=P26942401",
      "label": "APTARGROUP, INC. — Full financial report (2025 Y)",
      "documentId": "D-8ab120ff31d14209ba21d3b9b482703f"
    },
    {
      "id": "P65778214",
      "href": "https://app.finbar.com/go?id=P65778214",
      "label": "APTARGROUP, INC. — Full financial report (2025 Y)",
      "documentId": "D-8ab120ff31d14209ba21d3b9b482703f"
    },
    {
      "id": "P34900642",
      "href": "https://app.finbar.com/go?id=P34900642",
      "label": "APTARGROUP, INC. — Full financial report (2025 Y)",
      "documentId": "D-8ab120ff31d14209ba21d3b9b482703f"
    },
    {
      "id": "P78931723",
      "href": "https://app.finbar.com/go?id=P78931723",
      "label": "APTARGROUP, INC. — Full financial report (2025 Y)",
      "documentId": "D-8ab120ff31d14209ba21d3b9b482703f"
    },
    {
      "id": "P32346963",
      "href": "https://app.finbar.com/go?id=P32346963",
      "label": "APTARGROUP, INC. — Full financial report (2025 Y)",
      "documentId": "D-8ab120ff31d14209ba21d3b9b482703f"
    },
    {
      "id": "P62218729",
      "href": "https://app.finbar.com/go?id=P62218729",
      "label": "APTARGROUP, INC. — Full financial report (2025 Y)",
      "documentId": "D-8ab120ff31d14209ba21d3b9b482703f"
    },
    {
      "id": "P118933469",
      "href": "https://app.finbar.com/go?id=P118933469",
      "label": "APTARGROUP, INC. — Full financial report (2025 Y)",
      "documentId": "D-8ab120ff31d14209ba21d3b9b482703f"
    },
    {
      "id": "P27589424",
      "href": "https://app.finbar.com/go?id=P27589424",
      "label": "APTARGROUP, INC. — Full financial report (2025 Y)",
      "documentId": "D-8ab120ff31d14209ba21d3b9b482703f"
    },
    {
      "id": "P24632469",
      "href": "https://app.finbar.com/go?id=P24632469",
      "label": "APTARGROUP, INC. — Full financial report (2025 Y)",
      "documentId": "D-8ab120ff31d14209ba21d3b9b482703f"
    },
    {
      "id": "P100769735",
      "href": "https://app.finbar.com/go?id=P100769735",
      "label": "APTARGROUP, INC. — Full financial report (2025 Y)",
      "documentId": "D-8ab120ff31d14209ba21d3b9b482703f"
    },
    {
      "id": "P86421320",
      "href": "https://app.finbar.com/go?id=P86421320",
      "label": "APTARGROUP, INC. — Full financial report (2025 Y)",
      "documentId": "D-8ab120ff31d14209ba21d3b9b482703f"
    },
    {
      "id": "P44323451",
      "href": "https://app.finbar.com/go?id=P44323451",
      "label": "APTARGROUP, INC. — Full financial report (2025 Y)",
      "documentId": "D-8ab120ff31d14209ba21d3b9b482703f"
    },
    {
      "id": "P40207684",
      "href": "https://app.finbar.com/go?id=P40207684",
      "label": "APTARGROUP, INC. — Full financial report (2025 Y)",
      "documentId": "D-8ab120ff31d14209ba21d3b9b482703f"
    },
    {
      "id": "P90183207",
      "href": "https://app.finbar.com/go?id=P90183207",
      "label": "APTARGROUP, INC. — Full financial report (2025 Y)",
      "documentId": "D-8ab120ff31d14209ba21d3b9b482703f"
    },
    {
      "id": "P71762180",
      "href": "https://app.finbar.com/go?id=P71762180",
      "label": "APTARGROUP, INC. — Full financial report (2025 Y)",
      "documentId": "D-8ab120ff31d14209ba21d3b9b482703f"
    },
    {
      "id": "P50825336",
      "href": "https://app.finbar.com/go?id=P50825336",
      "label": "APTARGROUP, INC. — Full financial report (2025 Y)",
      "documentId": "D-8ab120ff31d14209ba21d3b9b482703f"
    },
    {
      "id": "P145380155",
      "href": "https://app.finbar.com/go?id=P145380155",
      "label": "APTARGROUP, INC. — Full financial report (2026 Q 2)",
      "documentId": "D-dc2e0b7f94a14638b8a95cac155aaad9"
    },
    {
      "id": "P145380157",
      "href": "https://app.finbar.com/go?id=P145380157",
      "label": "APTARGROUP, INC. — Full financial report (2026 Q 2)",
      "documentId": "D-dc2e0b7f94a14638b8a95cac155aaad9"
    },
    {
      "id": "P145380171",
      "href": "https://app.finbar.com/go?id=P145380171",
      "label": "APTARGROUP, INC. — Full financial report (2026 Q 2)",
      "documentId": "D-dc2e0b7f94a14638b8a95cac155aaad9"
    },
    {
      "id": "P145380175",
      "href": "https://app.finbar.com/go?id=P145380175",
      "label": "APTARGROUP, INC. — Full financial report (2026 Q 2)",
      "documentId": "D-dc2e0b7f94a14638b8a95cac155aaad9"
    },
    {
      "id": "P145380187",
      "href": "https://app.finbar.com/go?id=P145380187",
      "label": "APTARGROUP, INC. — Full financial report (2026 Q 2)",
      "documentId": "D-dc2e0b7f94a14638b8a95cac155aaad9"
    },
    {
      "id": "P145380191",
      "href": "https://app.finbar.com/go?id=P145380191",
      "label": "APTARGROUP, INC. — Full financial report (2026 Q 2)",
      "documentId": "D-dc2e0b7f94a14638b8a95cac155aaad9"
    },
    {
      "id": "https://aptar.com/en-us/products/pharmaceutical-apf-futurity-nasal-spray-recyclable",
      "href": "https://aptar.com/en-us/products/pharmaceutical-apf-futurity-nasal-spray-recyclable",
      "label": "aptar.com"
    },
    {
      "id": "https://aptar.com/en-us/products/pharmaceutical-uds-unidose-liquid-nasal-spray-system",
      "href": "https://aptar.com/en-us/products/pharmaceutical-uds-unidose-liquid-nasal-spray-system",
      "label": "aptar.com"
    },
    {
      "id": "https://aptar.com/en-us/products/essencia-elegant-fragrance-pump",
      "href": "https://aptar.com/en-us/products/essencia-elegant-fragrance-pump",
      "label": "aptar.com"
    },
    {
      "id": "https://aptar.com/en-us/products/micro-beverage-enhancer-closure",
      "href": "https://aptar.com/en-us/products/micro-beverage-enhancer-closure",
      "label": "aptar.com"
    },
    {
      "id": "https://aptar.com/en-us/closures/dispensing-caps-closures-for-beverage",
      "href": "https://aptar.com/en-us/closures/dispensing-caps-closures-for-beverage",
      "label": "aptar.com"
    },
    {
      "id": "T1105276",
      "href": "https://app.finbar.com/go?id=T1105276",
      "label": "APTARGROUP, INC. — Full financial report (2025 Y)",
      "documentId": "D-8ab120ff31d14209ba21d3b9b482703f"
    },
    {
      "id": "T5594450",
      "href": "https://app.finbar.com/go?id=T5594450",
      "label": "APTARGROUP, INC. — Full financial report (2025 Y)",
      "documentId": "D-8ab120ff31d14209ba21d3b9b482703f"
    },
    {
      "id": "T14007812",
      "href": "https://app.finbar.com/go?id=T14007812",
      "label": "APTARGROUP, INC. — Full financial report (2025 Y)",
      "documentId": "D-8ab120ff31d14209ba21d3b9b482703f"
    },
    {
      "id": "P104401032",
      "href": "https://app.finbar.com/go?id=P104401032",
      "label": "APTARGROUP, INC. — Full financial report (2025 Y)",
      "documentId": "D-8ab120ff31d14209ba21d3b9b482703f"
    },
    {
      "id": "P5016807",
      "href": "https://app.finbar.com/go?id=P5016807",
      "label": "APTARGROUP, INC. — Full financial report (2025 Y)",
      "documentId": "D-8ab120ff31d14209ba21d3b9b482703f"
    },
    {
      "id": "P301804",
      "href": "https://app.finbar.com/go?id=P301804",
      "label": "APTARGROUP, INC. — Full financial report (2025 Y)",
      "documentId": "D-8ab120ff31d14209ba21d3b9b482703f"
    },
    {
      "id": "https://aptar.com/en-us/about-aptar/history-of-innovation",
      "href": "https://aptar.com/en-us/about-aptar/history-of-innovation",
      "label": "aptar.com"
    },
    {
      "id": "https://aptar.com/en-us/news-events/aptar-celebrates-30-years-as-a-publicly-traded-company",
      "href": "https://aptar.com/en-us/news-events/aptar-celebrates-30-years-as-a-publicly-traded-company",
      "label": "aptar.com"
    },
    {
      "id": "https://investors.aptar.com/news/news-details/2018/Aptar-Announces-Chairman-King-Harris-to-Retire-in-May-George-Fotiades-Elected-as-Incoming-Chairman-of-the-Board-Two-New-Directors-Appointed/default.aspx",
      "href": "https://investors.aptar.com/news/news-details/2018/Aptar-Announces-Chairman-King-Harris-to-Retire-in-May-George-Fotiades-Elected-as-Incoming-Chairman-of-the-Board-Two-New-Directors-Appointed/default.aspx",
      "label": "investors.aptar.com"
    },
    {
      "id": "https://investors.aptar.com/news/news-details/2016/AptarGroup-Completes-Acquisition-of-Mega-Airless/default.aspx",
      "href": "https://investors.aptar.com/news/news-details/2016/AptarGroup-Completes-Acquisition-of-Mega-Airless/default.aspx",
      "label": "investors.aptar.com"
    },
    {
      "id": "https://aptar.com/en-us/news-events/aptar-completes-acquisition-of-csp-technologies",
      "href": "https://aptar.com/en-us/news-events/aptar-completes-acquisition-of-csp-technologies",
      "label": "aptar.com"
    },
    {
      "id": "P44244551",
      "href": "https://app.finbar.com/go?id=P44244551",
      "label": "APTARGROUP, INC. — Full financial report (2025 Y)",
      "documentId": "D-8ab120ff31d14209ba21d3b9b482703f"
    },
    {
      "id": "https://aptar.com/en-us/news-events/aptar-closures-acquires-majority-stake-of-gulf-closures-adding-manufacturing-capabilities-in-the-middle-east",
      "href": "https://aptar.com/en-us/news-events/aptar-closures-acquires-majority-stake-of-gulf-closures-adding-manufacturing-capabilities-in-the-middle-east",
      "label": "aptar.com"
    },
    {
      "id": "https://aptar.com/en-us/news-events/aptar-acquires-sommaplast-a-specialized-provider-of-oral-dosing-pharma-packaging-solutions",
      "href": "https://aptar.com/en-us/news-events/aptar-acquires-sommaplast-a-specialized-provider-of-oral-dosing-pharma-packaging-solutions",
      "label": "aptar.com"
    }
  ]
}